INTRODUCTION
============

SNARE proteins are well recognized as mediators of membrane fusion within the endomembrane system of eukaryotic cells ([@B83]; [@B67]; [@B75]). Syntaxins, a conserved family of SNARE proteins ([@B81], [@B82]), are central to all SNARE complexes. At least 16 syntaxins are encoded in the human genome ([@B32]), and each localizes to specific membrane domains or organelles in which they carry out specific membrane fusion reactions. The diversity of syntaxins and their cognate SNARE binding partners are thought to contribute to the overall fidelity and specificity of membrane trafficking ([@B66]; [@B36]). Others and we have previously reported that syntaxin 3 (Stx3) localizes to the apical plasma membrane in a wide variety of polarized epithelial cells ([@B45], [@B46], [@B47]; [@B16]; [@B80]; [@B43]). Apical targeting of Stx3 is governed by an apical targeting signal in its N-terminal domain, and its mutation causes mislocalization of Stx3, improper trafficking of apical membrane proteins, and cell polarity defects ([@B77]; [@B68]).

In addition to the apical plasma membrane, a fraction of Stx3 also localizes to late endosomal/lysosomal compartments ([@B45]; [@B16]). It is unknown how Stx3 traffics to these organelles or what its function there may be. We have previously shown that newly synthesized Stx3 is initially delivered to both the apical and basolateral plasma membrane ([@B68]). Because Stx3 is undetectable at the basolateral membrane at steady state, this suggests that any basolaterally "misdelivered" Stx3 must be rapidly removed, possibly by endocytosis. Whether and how any syntaxins undergo endocytosis is poorly understood. However, Stx8 interacts with the potassium channel TASK-1, which facilitates the clathrin-mediated endocytosis of both proteins leading to regulation of TASK-1 abundance at the plasma membrane ([@B64]). Other syntaxins also interact with ion channels and regulate their activity and/or localization ([@B3]; [@B42]; [@B22]; [@B72]), which has led to the idea that syntaxins have additional functions unrelated to membrane fusion.

Curiously, Stx3 has been identified among proteins found in apically secreted exosomes but not basolateral exosomes ([@B79]). In vivo, Stx3 is also found in urinary exosomes, presumably due to apical secretion from tubule epithelial cells ([@B24]). Exosomes are small vesicles that are secreted by the fusion of intracellular multivesicular bodies (MVBs) with the plasma membrane ([@B41]; [@B51]). MVBs, in turn, are a class of late endosomes containing intraluminal vesicles (ILVs), which are formed by the invagination of the limiting membrane of the endosome. MVBs either fuse with lysosomes for the degradation of their membranous contents or with the plasma membrane for the secretion of exosomes. Conjugation of membrane proteins with ubiquitin can serve as a signal that directs these membrane proteins into the MVB pathway ([@B33]; [@B37]; [@B48]; [@B74]). In particular, monoubiquitination has been identified as an endocytosis signal that directs plasma membrane proteins to the endocytic pathway ([@B30]).

Human cytomegalovirus (HCMV) is a member of the enveloped herpes virus family, and a widespread human pathogen that causes asymptomatic infections that often become latent. However, in immunocompromised persons, HCMV infections can be life-threatening, and congenital infection can lead to significant developmental defects ([@B88]; [@B87]). HCMV acquires its final envelope in intracellular membranes before its secretion, although the mechanisms underlying these processes are poorly understood. We have previously shown that HCMV strongly induces the expression of Stx3 and that Stx3 is required for the production of infectious viral particles through a mechanism that likely involves late endosomes/lysosomes ([@B12]). How Stx3 may be involved in HCMV virion production and secretion is unknown. However, according to some models, HCMV virions bud into intracellular membrane organelles which may subsequently fuse with the plasma membrane in a mechanism that at least superficially resembles the mechanism of secretion of exosomes from MVBs ([@B11]; [@B18]; [@B1]).

We report here that Stx3 can undergo monoubiquitination on lysines in its juxtamembrane region. Stx3 is rapidly endocytosed from the basolateral domain of polarized epithelial cells but not from the apical domain. A ubiquitination-deficient mutant of Stx3 (Stx3-5R) exhibits delayed basolateral endocytosis, exclusion from the endosomal pathway, and diminished secretion in apical exosomes. Expression of Stx3-5R acts in a dominant-negative manner and decreases the exosomal secretion of GPRC5B, a known apical exosome cargo. Finally, expression of Stx3-5R strongly inhibits the number of infectious HCMV secreted virions. Altogether these results suggest that Stx3 has a second function in addition to its established role in apical membrane fusion. Stx3 is ubiquitinated and actively transported from the basolateral membrane to the endosomal/MVB pathway and excreted apically in exosomes. Our results suggest that Stx3 is not only a passive cargo in this pathway but facilitates the efficient trafficking of other cargoes into apical exosomes. In addition, our results also suggest that HCMV exploits this cellular apical exosomal pathway to accomplish the efficient release of viral particles.

RESULTS
=======

Stx3 undergoes monoubiquitination
---------------------------------

Although the bulk of Stx3 resides on the apical plasma membrane in polarized epithelial cells, a portion of Stx3 also localizes to a late endosomal population ([@B45]; [@B16]). We hypothesized that ubiquitination may be involved in the targeting of endosomal Stx3. To test whether Stx3 can undergo ubiquitination, endogenous Stx3 was immunoprecipitated from polarized Caco2 intestinal epithelial cells and probed for ubiquitin by immunoblotting. A specific, ubiquitin-positive band was detected migrating at a position ∼9 kDa larger than Stx3 ([Figure 1A](#F1){ref-type="fig"}) suggesting that a fraction of Stx3 undergoes monoubiquitination. To confirm this finding, myc-tagged ubiquitin and untagged Stx3 were coexpressed in HEK293T cells followed by immunoprecipitation. Monoubiquitinated Stx3 can be detected as a band with an increased molecular weight of ∼9 kDa ([Figure 1B](#F1){ref-type="fig"}). Using Madin-Darby canine kidney (MDCK) cells stably expressing either C-terminally myc-tagged Stx3 or Stx4 in a doxycycline-inducible manner ([@B47]), a similar ∼9 kDa shifted, ubiquitin-positive band appears for Stx3 but not Stx4, suggesting that ubiquitination is not a universal modification of all syntaxins ([Figure 1C](#F1){ref-type="fig"}). Treatment with the protease inhibitor ALLN leads to a strong increase in the level of monoubiquitinated Stx3 ([Figure 1D](#F1){ref-type="fig"}). The effect of ALLN suggests that the ubiquitinated species is either quickly degraded or deubiquitinated in the cell. ALLN has previously been suggested to inhibit deubiquitinating enzymes ([@B84]). Altogether these data indicate that a short-lived population of Stx3 can undergo monoubiquitination in multiple cell lines and under various experimental conditions.

![Stx3 is ubiquitinated. (A) Endogenous Stx3 was immunoprecipitated (IP) from Caco2 cells and immunoblotted (IB) with an antibody to ubiquitin (Ub) and Stx3. Nonspecific rabbit IgG antibody was used for control (lane C). (B) HEK293T cells were transfected with untagged Stx3 and myc-ubiquitin constructs. Lysates were subjected to IP with an anti-Stx3 antibody and analyzed by IB with anti-myc antibody. Cell lysates used as input for the IP were blotted with anti-Stx3 antibody. The ubiquitinated Stx3 band identified by both anti-myc and anti-Stx3 antibodies is indicated by an arrow. (C) Doxycycline-inducible MDCK cells expressing Stx3 or Stx4, both myc-tagged, were lysed, immunoprecipitated with anti-myc antibodies, and analyzed by immunoblot with antibodies to myc or Ubi. Bottom panel: total lysates used for the IP were blotted with anti-myc antibody. (D) Untransfected MDCK cells or MDCK cells stably expressing double myc-tagged Stx3 were treated with 10μM ALLN (+ALLN) or without (−ALLN) for 16 h. Lysates were subjected to IP with anti-myc antibody and analyzed by IB with anti-myc antibody.](2843fig1){#F1}

Ubiquitination occurs in the juxtamembrane region of Stx3
---------------------------------------------------------

Deletion mutants were used to identify the ubiquitination site(s) in Stx3 ([Figure 2A](#F2){ref-type="fig"}). Deletion of the transmembrane domain prevents ubiquitination, suggesting that membrane anchorage is required ([Figure 2B](#F2){ref-type="fig"}). Constructs containing either the N- or C-terminal halves, respectively, of the cytoplasmic domain of Stx3 in addition to the transmembrane domain could both be ubiquitinated ([Figure 2](#F2){ref-type="fig"}). The only lysine residues in common between these two constructs are the two lysines immediately preceding the transmembrane domain which are part of a basic motif containing six lysine residues ([Figure 2A](#F2){ref-type="fig"}). Similar basic motifs are present in most other SNARE proteins that contain C-terminal transmembrane anchors ([@B82]), but the primary amino acid sequences of these motifs are not well conserved between different syntaxins ([Figure 2C](#F2){ref-type="fig"}). To investigate possible ubiquitination in this basic motif of Stx3, lysines were progressively replaced with arginines in order to prevent ubiquitination without disrupting the positive charges ([Figure 2D](#F2){ref-type="fig"}). Mutation of all six lysines (6R mutant) or of the most C-terminal five lysines (5R mutant) completely prevented ubiquitination ([Figure 2E](#F2){ref-type="fig"}). Interestingly, the 2R, 3R, and 4R mutants did not prevent ubiquitination. Given the positions of these mutations, we conclude that any of the C-terminal five lysine residues can be subject to ubiquitination. This suggests that ubiquitination of this motif is region specific but not strictly sequence specific.

![Ubiquitination occurs in the juxtamembrane region of Stx3. (A) Schematic representation of Stx3 wild-type and mutant constructs used for expression. Residues in the polybasic juxtamembrane region (PB) of wild-type Stx3 are shown. Two myc-epitope tags (white circles) and one His6 tag (black circle) were added to the COOH termini; PB, polybasic; TM, transmembrane domain. (B) HEK293T cells were transiently transfected with the indicated constructs, plated for 24 h and incubated with or without ALLN. Lysates were subjected to IP with anti-myc antibody and analyzed by IB with anti-Ubi. Bottom: Total lysates used for IP blotted with anti-myc antibody. Cells without construct transfection (lane C) serve as a negative control for the IP. (C) Sequence alignment of the juxtamembrane region of human plasma membrane syntaxins 1A, 2, 3, and 4, SwissProt accession numbers Q16623, P32856, Q13277, and Q12846 respectively. (D) Stx3 lysine mutant constructs used in this study (region 241-268 is shown). Lysine residues mutated to arginine are in bold letters. (E) Anti-myc Western blot of HEK293T treated with and without ALLN transiently expressing lysine mutants subjected to anti-myc IP. (F) Two different stable clones of DOX inducible MDCK cells stably transfected for Stx3-5R, c14, and c21, were subjected to IP with anti-myc antibody and IB with antibodies against Ubi, SNAP-23, and munc18b. (G) Immunocytochemistry of DOX-induced Stx3, Stx3-5R, or Stx3-6R (green) expresses in polarized MDCK cells cultured on Transwell filters. Scale bar: 10 μm.](2843fig2){#F2}

We chose the "5R" mutant as a nonubiquitinatable Stx3 for further study and stably expressed this mutant in MDCK cells in a doxycycline-inducible manner. Stx3-5R still binds efficiently to the endogenous SNARE binding partner SNAP-23 and the SNARE regulator munc18b similar to wild-type Stx3 ([Figure 2F](#F2){ref-type="fig"}), suggesting that the mutations in Stx3-5R do not cause detrimental structural defects that disrupt normal binding interactions. The steady-state localization of Stx3-5R and Stx3-6R at the apical plasma membrane mirrors wild-type localization ([Figure 2G](#F2){ref-type="fig"}).

Ubiquitination directs basolateral Stx3 to the endocytic pathway and influences cargo sorting
---------------------------------------------------------------------------------------------

Previously we reported that, in addition to the apical plasma membrane, a fraction of Stx3 localizes to late endosomes/lysosomes ([@B45]). To test whether this localization is ubiquitination dependent, we investigated the intracellular localization of wild-type Stx3 or Stx3-5R by immunofluorescence microscopy in MDCK cells. As expected, wild-type Stx3 extensively colocalizes with the late endosomal/lysosomal marker LAMP-2. In contrast, Stx3-5R exhibits very little colocalization with LAMP-2 ([Figure 3A](#F3){ref-type="fig"}) suggesting that ubiquitination may be required for Stx3 targeting into the late endosomal/lysosomal pathway.

![Ubiquitination directs basolateral Stx3 to the endocytic pathway and influences cargo sorting to endosomes. (A) Immunofluorescence microscopy showing reduced colocalization of Stx3-5R with LAMP-2 compared with wild-type Stx3. Cells were cultured on coverslips, treated with DOX for 16 h and stained with Stx3 (green) and LAMP-2 (red) antibodies. Intensity of pixels along white lines in micrographs for each channel plotted in graphs under micrographs. Scale bar: 10 μm. (B) Wild-type Stx3 or Stx3-5R (c14) expression was induced with DOX for 16 h in stably transfected MDCK cells grown at confluence for 4 d on Transwell filters. For endocytosis assay anti-myc 9E10 ascites was added to apical or basolateral media and incubated at 4°C before being washed off and incubated at 37°C for indicated times. Cells were fixed and stained for Stx3 (myc), green; M6PR, red; and nuclei (DAPI), blue. Scale bar: 10 μm. (C) MDCK cells stably expressing Stx3 or Stx3-5R were grown on coverslips and transiently transfected with GFP-Rab5 or GFP-Rab5Q79L. Twenty-four hours after transfection, Stx3 or Stx3-5R expression was induced with DOX for 16 h. Cells were fixed and processed for immunocytochemistry. Stx3 (myc), red; Rab5, green; and nuclei (DAPI), blue. Scale bar: 10 μm. (D) MDCK cells were grown on coverslips and transiently transfected with mCherry-Rab5-Q79L, GFP-GPRC5B, and either Stx3 or Stx3-5R. Thirty-six hours after transfection cells were fixed and processed for immunocytochemistry. Stx3 (myc), blue; Rab5, red; and GPRC5B, green. Scale bar: 10 μm. (E) Quantification of mean intensity of GPRC5B within enlarged endosomes from either Stx3 or Stx3-5R cells. Error bars represent SEM. \*\*\**P* \< 0.001, Student's unpaired *t* test.](2843fig3){#F3}

To investigate this novel role for ubiquitination of Stx3, we took advantage of the extracellular myc-epitope tag ([Figure 2A](#F2){ref-type="fig"}) to follow the endocytosis of Stx3 from either the basolateral or apical plasma membrane. Polarized MDCK cells cultured on Transwell filters were incubated with anti-myc antibody in the media compartment in contact with either the apical or the basolateral domain. After antibody addition, cells were washed, and incubated at the indicated time points. Any Stx3 that had been tagged with the antibody on either cell surface was visualized by immunofluorescence microscopy ([Figure 3B](#F3){ref-type="fig"}). Surprisingly, despite the fact that wild-type Stx3 is undetectable at the basolateral membrane at steady state ([Figure 2G](#F2){ref-type="fig"}), after antibody addition into the basolateral chamber a strong signal of antibody-tagged Stx3 is observed on the basolateral membrane at 5 min ([Figure 3B](#F3){ref-type="fig"}). Within 20 min, antibody-tagged Stx3 moves to intracellular vesicles that costain with the M6PR (mannose 6-phosphate receptor), a marker of the late endosomal/lysosomal pathway. A fraction of the basolaterally internalized Stx3 signal remains in M6PR-positive organelles after 60 min but another fraction appears to be able to reach the apical plasma membrane by that time. In contrast, when the myc antibody is added to the apical chamber antibody-tagged wild-type Stx3 remains at the apical membrane with no evidence of internalization after 60 min ([Figure 3B](#F3){ref-type="fig"}). We conclude that a sizable fraction of wild-type Stx3 is targeted to the basolateral domain from which it is rapidly removed by endocytosis followed by targeting to the late endosomal/lysosomal pathway. In contrast, the fraction of Stx3 that has reached the apical membrane is stable at this location and does not undergo endocytosis. Therefore apical polarity of Stx3 is achieved, at least in part, by selective removal from the "incorrect" plasma membrane domain.

The ubiquitination-deficient Stx3-5R mutant is still efficiently tagged by the myc antibody at both the basolateral and apical membranes. In contrast to wild-type Stx3, however, Stx3-5R does not undergo rapid endocytosis from the basolateral membrane, and does not exhibit targeting to M6PR-positive organelles. Eventually, by 60 min, a fraction of Stx3-5R reaches the apical membrane. We conclude that the inability to ubiquitinate Stx3 leads to a defect in efficient basolateral endocytosis and targeting to the late endosomal/lysosomal pathway.

To further explore the internalization and endosomal trafficking of Stx3 we utilized the GTPase-deficient Q79L mutant of Rab5 ([@B2]). Proteins internalized via clathrin-mediated endocytosis accumulate in early endosomes in the presence of this mutant and these endosomes dramatically enlarge in size ([@B57]; [@B73]; [@B86]; [@B23]). Stx3 is efficiently targeted to Rab5-Q79L-positive enlarged endosomes and localizes both at the limiting membrane and prominently on ILVs of these endosomes ([Figure 3C](#F3){ref-type="fig"}). This result suggests that Stx3 is internalized to ILVs. In contrast, Stx3-5R is absent from both the limiting membrane and ILVs of Rab5-Q79L-positive enlarged endosomes, suggesting again that ubiquitination is required for endocytosis of Stx3 and trafficking to endosomes ([Figure 3C](#F3){ref-type="fig"}).

The orphan G-protein coupled receptor GPRC5B is excreted with apical exosomes in MDCK cells and has been shown to localize to ILVs in enlarged Rab5-Q79L-positive early endosomes ([@B39]). Therefore we investigated GPRC5B as an established cargo protein that traffics via endosomal ILVs en route the apical exosomal pathway in MDCK cells. mCherry-tagged Rab5-Q79L, green fluorescent protein (GFP) -tagged GPRC5B and Stx3 or Stx3-5R were coexpressed in MDCK cells. As anticipated, GPRC5B and Stx3 localize to the lumens of enlarged early endosomes ([Figure 3](#F3){ref-type="fig"}, D and E). However, when Stx3-5R is expressed, neither Stx3-5R itself nor GPRC5B are found in the endosomal lumen. This result suggests the possibility that Stx3 not only traffics to ILVs in the endosomal pathway but may also play a role in facilitating the trafficking of other proteins in this pathway. Overexpression of the ubiquitination-defective Stx3-5R mutant may therefore act as a dominant-negative inhibitor of this pathway.

Ubiquitination directs Stx3 and cargo to exosomes
-------------------------------------------------

Stx3 and its binding partner munc18b have been identified in apically released exosomes from intestinal epithelial cells ([@B79]) and in a proteomics screen of urinary exosomes ([@B24]). We confirmed the presence of Stx3 and munc18b in human urinary exosomes ([Figure 4A](#F4){ref-type="fig"}). Besides the relatively abundant signal for Stx3 in urinary exosomes, Stx2 could also be detected ([Figure 4B](#F4){ref-type="fig"}), but not the basolateral membrane-specific Stx4 ([@B45]) or the neuronal Stx1A ([Figure 4B](#F4){ref-type="fig"}). Next we isolated exosomes secreted from Caco-2 cells and found endogenously expressed Stx3 to be present ([Figure 4C](#F4){ref-type="fig"}). These results confirm that endogenous Stx3 is secreted in exosomes both in vivo and in vitro.

![Ubiquitination directs Stx3 and cargo to exosomes. (A) Exosomes from 60 ml of human urine (from two volunteers, 1 and 2) were isolated by differential ultracentrifugation. Indicated volume amount from a total volume of 50μl were analyzed by immunoblotting for TSG101 (exosome positive marker), Na/K ATPase (exosome negative marker) ([@B71]; [@B78]), Stx3, and munc18b. Total lysates from Caco-2 cells were used as antibody control (L). (B) Human urine exosomes were analyzed for the indicated plasma membrane syntaxins. Lysates from MDCK cells with stable expression for the respective syntaxins were used as positive controls. (C) Exosomes from Caco-2 conditioned media were isolated and analyzed as above. (D) HEK293T cells were transiently transfected with Stx3, Stx3-5R, and Stx4 (all myc tagged) plasmids. Lane C represents cells without transfection. Forty-eight hours after transfection exosomes from the media and cell lysates were analyzed by immunoblotting with anti-myc, anti-calnexin (exosome negative marker), and anti-flotillin-1 (exosome positive marker). As a specificity control, Stx4 was included, which was not appreciably secreted in exosomes. Relative intensity of myc band normalized to flotillin is below each lane. (E) DOX induced MDCK expressing Stx3 or Stx3-5R were transiently transfected with GFP-GPRC5B. Exosomes were purified from media after 48 h and subjected to immunoblotting. Performed in triplicate. (F) Quantification of relative intensity of GPRC5B bands in Stx3 or Stx3-5R exosome samples from E. Error bars represent SEM of experiment performed in triplicate. \**P* \< 0.05, Student's unpaired *t* test. (G) Immunoblot of MeWo cells transduced with lentivirus delivering shRNA \#304, targeting Stx3, or shRNA scrambled control. (H) Table showing concentration of exovesicles in media collected from cells in G.](2843fig4){#F4}

To determine whether ubiquitination is necessary for exosomal secretion of Stx3, we expressed myc-tagged Stx3 or Stx3-5R in HEK293T cells and isolated exosomes from the cell culture medium. Although wild-type Stx3 is readily detectable in exosomes, only trace amounts of Stx3-5R were found ([Figure 4D](#F4){ref-type="fig"}), suggesting that ubiquitination is required to direct Stx3 to the endosomal pathway leading to secretion in exosomes.

Because our above data suggested that Stx3 may play a role in facilitating the trafficking of GPRC5B into the endosomal pathway, we next investigated whether the exosomal secretion of GPRC5B is affected by Stx3-5R. GPRC5B was expressed in MDCK cells stably expressing either Stx3 or Stx3-5R and the secreted exosomes were isolated. Secretion of the general exosomal marker flotillin was unaffected by expression of Stx3 or Stx3-5R ([Figure 4E](#F4){ref-type="fig"}). In contrast, the exosomal secretion of GPRC5B was reduced by ∼50% in cells expressing Stx3-5R ([Figure 4F](#F4){ref-type="fig"}). This result suggests that Stx3 may facilitate the exosomal trafficking of specific cargo proteins as opposed to the secretion of exosomes per se. To further test whether Stx3 is required for the overall ability of cells to secrete exosomes, we knocked down the expression of endogenous Stx3 by stable short hairpin RNA (shRNA) expression ([Figure 4G](#F4){ref-type="fig"}) in MeWo cells as previously reported (Cepeda and Fraile-Ramos, 2011) and quantified the number of secreted exosomal particles by nanoparticle tracking analysis (Carr *et al.*, 2007). No substantial difference was observed ([Figure 4H](#F4){ref-type="fig"}).

Altogether these results suggest that Stx3 is not required for the biogenesis and secretion of exosomes but likely plays a role in the targeting of specific proteins into the exosomal pathway.

Ubiquitination of Stx3 is required for HCMV secretion
-----------------------------------------------------

We have previously shown that HCMV infection induces a strong increase in the expression of endogenous Stx3, and that Stx3 can be detected in secreted virions ([@B12]). Knockdown of Stx3 expression inhibits the production and secretion of HCMV virions ([@B12]), a process that also involves Rab27a ([@B18]), a small GTPase required for exosome excretion ([@B58]). These findings suggest that Stx3 is required for a key step in the HCMV life cycle, and we hypothesized that its role may depend on its ability to be ubiquitinated and target to the endosomal/exosomal pathway. To test this, the expression of endogenous Stx3 in human foreskin fibroblast (BJ1) cells was knocked down by shRNA ([Figure 5A](#F5){ref-type="fig"}) and then "rescued" by lentiviral expression of Stx3 or Stx3-5R cDNA constructs resistant to the shRNA ([Figure 5A](#F5){ref-type="fig"}). When these cells were infected with a recombinant strain of HCMV containing a GFP reporter under an HCMV early promoter ([@B50]) and the number of infected cells was determined by GFP expression, we did not observe differences between the cell lines ([Figure 5B](#F5){ref-type="fig"}). Knockdown of endogenous Stx3 expression caused a strong reduction of the amount of infectious particles released into the supernatant ([Figure 5C](#F5){ref-type="fig"}), consistent with previous results ([@B12]). This effect was completely rescued by reexpression of wild-type Stx3 but not by reexpression of Stx3-5R ([Figure 5C](#F5){ref-type="fig"}). Moreover, exogenous expression of Stx3-5R alone---without knocking down endogenous Stx3 expression---strongly reduced the number of infectious particles released ([Figure 5C](#F5){ref-type="fig"}), indicating again that this mutant acts as a dominant-negative inhibitor. Altogether these results indicate that ubiquitination of Stx3 plays a key role in the life cycle of HCMV and suggest that HCMV uses a pathway similar to the exosomal pathway for its secretion.

![Ubiquitination of Stx3 is required for HCMV secretion. BJ1 cells expressing shRNA-resistant-STX3 or shRNA-resistant-Stx3-5R constructs were transduced with scrambled control and STX3 \#304 shRNAs and infected with RecCMV at 0.3 MOI. (A) Immunoblot analysis of these cells at 4 d postinfection with antibodies against STX3 and actin. (B) Flow cytometry analysis for GFP expression. (C) At 5 dpi, supernatants were harvested and the number of extracellular infectious viruses was determined on fresh BJ1 cells. Data are means and SDs for quadruplicate samples from a representative experiment out of a total of eight similar experiments. Similar effects were observed in all experiments. \*\*\**P* \< 0.005.](2843fig5){#F5}

DISCUSSION
==========

This study illustrates a novel trafficking pathway for Stx3 and suggests a function of Stx3 that may be independent of its function in membrane fusion. Previous studies have shown that Stx3 localizes to the apical plasma membranes of various types of polarized epithelial cells and that it plays a role in apical membrane trafficking, presumably by mediating fusion of transport vesicles that reach the apical plasma membrane ([@B16]; [@B20]; [@B65]; [@B6]; [@B56]; [@B43]). However, Stx3 has also been detected on intracellular membrane compartments including late endosomes/lysosomes ([@B45]; [@B16]), secretory granules in pancreatic acinar cells ([@B21]), mast cells ([@B26]; [@B29]), and parotid acinar cells ([@B10]), tubulovesicles containing the H,K-ATPase in gastric parietal cells ([@B60]), the phagosomal membrane of macrophages ([@B27]), and on melanosomes in melanocytes ([@B85]). It is unclear whether Stx3 functions in these intracellular organelles as a membrane fusion protein or whether it may have a separate function.

In MDCK cells, newly synthesized Stx3 reaches both the apical and basolateral plasma membranes on direct routes after passage through the Golgi in a relatively nonpolarized manner ([@B68]) and it remained unclear how apical polarity is eventually achieved. In addition, it has remained unknown how Stx3 may be targeted to any of the intracellular organelles mentioned above. Our results now suggest that Stx3 is targeted to the endosomal/lysosomal pathway via endocytosis from the basolateral plasma membrane. Our finding that myc-tagged Stx3 can be efficiently detected by binding to the myc antibody at the basolateral membrane ([Figure 3B](#F3){ref-type="fig"}) is consistent with our previous finding that ∼25% of newly synthesized Stx3 is initially targeted to the basolateral membrane in polarized MDCK cells ([@B68]). Intriguingly, at steady state, Stx3 is undetectable at the basolateral membrane, which is consistent with our finding that Stx3 is rapidly endocytosed from this membrane. In contrast, we saw no evidence of endocytosis of Stx3 from the apical membrane. Altogether these findings suggest that selective removal from the basolateral membrane and stabilization at the apical membrane greatly contribute to the overall polarized distribution of Stx3 in epithelial cells.

Our results suggest that monoubiquitination of Stx3 acts as an internalization signal at the basolateral membrane. Similarly, monoubiquitination has been found to induce endocytosis of several other integral membrane proteins ([@B62]; [@B14]; [@B31]; [@B69]). We speculate that Stx3 is recognized and ubiquitinated by an E3 ubiquitin-protein ligase that is specific to the basolateral membrane, but such an enzyme remains to be identified. A few previous studies have indicated that other syntaxins can be ubiquitinated. Stx1B was found to be polyubiquitinated by the novel E3 ubiquitin-protein ligase Staring, which leads to its proteasomal degradation ([@B13]). Proteomic screens found evidence for ubiquitination of several syntaxins among many other proteins ([@B15]; [@B38]; [@B54]).

We show that Stx3 is primarily monoubiquitinated and that this modification occurs in its polybasic juxtamembrane region. This region contains six lysine residues, all or most of which appear to be able to serve as ligation sites for ubiquitin. All other syntaxins have similar charged polybasic regions near the transmembrane domain raising the possibility that other syntaxins may be modified there, too. For example, syntaxin 5 is monoubiquitinated at a residue in the polybasic region as well ([@B34]). Both monoubiquitination events, either Stx3 or Stx5, induce dominant-negative behavior preventing cargo sorting or proper Golgi assembly, respectively. We hypothesize that ubiquitinated Stx3 may be unable to form the SNARE complex, ensuring that mistargeted Stx3 on the basolateral membrane cannot function in inappropriate membrane fusion of apically destined vesicles. This intriguing possibility remains to be investigated but would provide an elegant mechanism to enhance overall specificity in membrane trafficking.

Basolaterally endocytosed Stx3 rapidly reaches M6PR-positive endosomes ([Figure 3B](#F3){ref-type="fig"}). Furthermore, Stx3 is targeted to ILVs in Rab5-Q79L-positive endosomes ([Figure 3C](#F3){ref-type="fig"}). Finally, Stx3 can be recovered from apically secreted exosomes ([Figure 4](#F4){ref-type="fig"}). Together these results indicate that a fraction of endocytosed Stx3 is transported along the endosomal/MVB/exosomal pathway. Human urine is a relatively rich source of exosomal Stx3 ([Figure 4](#F4){ref-type="fig"}; [@B24]), suggesting that a significant quantity of Stx3 is targeted along this route in renal tubule epithelial cells and finally excreted apically into the urinary space. The purpose of the presence of Stx3 in exosomes is unclear. One possibility is that exosomal secretion is a mechanism of eliminating excess cellular Stx3, although this would seem to be a relatively wasteful mechanism compared with lysosomal degradation. Another possibility is that Stx3 has a distinct function in exosomes, although it would probably be unrelated to any membrane fusion function because topologically Stx3 protrudes into the lumen of exosomes and would be inaccessible from the outside. A third possibility---which we consider most likely---is that Stx3 functions as a trafficking adaptor directing cargo proteins into the apical exosomal secretion pathway and as a consequence it is eventually incorporated in exosomes. A finding in support of this possibility is that the ubiquitination-deficient mutant, Stx3-5R, appears to act as a dominant-negative inhibitor of GPRC5B into ILVs ([Figure 3D](#F3){ref-type="fig"}) and its apical exosomal secretion ([Figure 4](#F4){ref-type="fig"}, E and F). The finding that Stx3-5R does not affect exosomal secretion of the "generic" exosomal marker flotillin 1 ([Figure 4](#F4){ref-type="fig"}, D and E), and that inhibition of Stx3 expression does not affect the number of secreted exosomes ([Figure 4](#F4){ref-type="fig"}, G and H), suggests that Stx3 functions specifically in the targeting of certain cargoes into the endosomal/MVB/exosomal pathway as opposed to being required for the generation/secretion of exosomes per se*.* Besides the abundant presence of Stx3 in urinary exosomes, GPRC5B is also secreted in urinary exosomes and its level is dramatically increased in patients with acute kidney injury ([@B39]).

On the basis of the unaltered molecular weight of Stx3 recovered from exosomes ([Figure 4](#F4){ref-type="fig"}), we conclude that exosomal Stx3 is not ubiquitinated. However, since the nonubiquitinatable mutant, Stx3-5R, fails to traffic to exosomes, we conclude that ubiquitination of Stx3 is required for its entry into the endosomal/MVB/exosomal pathway, most likely at the level of endocytosis at the plasma membrane. Many membrane proteins that traffic to ILVs are ubiquitinated ([@B4]; [@B61]; [@B70]; [@B28]), however, deubiquitinating enzymes typically remove ubiquitin from such proteins before the final incorporation into ILVs ([@B49]; [@B40]; [@B63]; [@B28]). Therefore we propose that Stx3 is similarly deubiquitinated during this step but the responsible deubiquitinating enzyme remains to be identified.

Remarkably, the Stx3-5R mutant strongly inhibits the number of infectious HCMV virions secreted into the supernatant of infected cells ([Figure 5C](#F5){ref-type="fig"}). It is not well understood how HCMV virions are assembled and acquire their membrane envelope. However, this process occurs in an intracellular assembly site and it has been suggested that virions of HCMV and related viruses bud into a membrane organelle that subsequently fuses with the plasma membrane of the host cell to release complete, enveloped virions. Previous work has suggested that this process shares similarities with the invagination of ILVs during the formation of MVBs, and that HCMV and related viruses may exploit an exosome-like, Rab27a-dependent pathway ([@B7]; [@B53]; [@B59]; [@B76]; [@B11]; [@B18]; [@B35]).

We have previously shown that HCMV infection leads to a dramatic up-regulation of Stx3 expression in the host cell and that Stx3 is required for efficient virus production ([@B12]). Furthermore, Stx3 is present in purified HCMV virions ([@B12]) suggesting that it is incorporated into the viral envelope during viral assembly. Interestingly, a virally encoded miRNA (hcmv-miR-US33-5p) inhibits the expression of cellular Stx3 leading to inhibition of viral replication, and it has been proposed that this mechanism facilitates establishment or maintenance of HCMV latency ([@B25]). SNAP-23, the SNARE binding partner of Stx3 ([@B68]), has also been shown to be required for efficient production of HCMV virions ([@B44]), suggesting that Stx3 and SNAP-23 may function as a complex in this process. Our results confirm that knocking down the expression of endogenous Stx3 with shRNA does not interfere with the ability of HCMV to infect cells but strongly inhibits viral particle secretion ([Figure 5](#F5){ref-type="fig"}). Expression of shRNA-resistant Stx3 rescues this effect but expression of the shRNA-resistant Stx3-5R mutant does not ([Figure 5C](#F5){ref-type="fig"}). Furthermore, expression of Stx3-5R alone, over the background of endogenous wild-type Stx3, inhibits the number of secreted HCMV virions, suggesting again that this mutant acts as a dominant-negative inhibitor. Altogether these results suggest that the ability of Stx3 to be ubiquitinated is essential for the life cycle of HCMV. We propose that ubiquitinated Stx3 functions in the assembly of enveloped HCMV virions in a trafficking pathway that is analogous to the exosomal pathway. It is possible that Stx3 may physically interact with one or more viral proteins and facilitates their trafficking to ILV-like vesicles, although this remains to be investigated.

MATERIALS AND METHODS
=====================

Reagents and antibodies
-----------------------

A mouse monoclonal antibody (mAb) against the N-terminal residues 1-146 of rat Stx3 was generated. This antibody (clone 1-146) is reactive against the rat, mouse, and human proteins and is available from MilliporeSigma (MAB2258). Anti-myc-epitope tag antibody was generated from the original hybridoma cells (9E10; American Type Culture Collection) and used for immunoblots and immunoprecipitation. Anti-ZO1 rat antibody (R40.76), anti-calnexin rabbit polyclonal antibody, and anti-TSG101 mouse mAb were purchased from Santa Cruz Biotechnology. Anti--β-actin clone AC-15 was obtained from Sigma-Aldrich. Anti--myc tag, clone 4A6 from Millipore was used for immunofluorescence. Affinity-purified polyclonal antibodies against a C-terminal peptide of human SNAP-23 have been described previously ([@B68]). Polyclonal antibody against Munc18-2 (munc18b) was a kind gift from Ulrich Blank (INSERM U699, Faculté de Médecine Paris 7). Anti-Na/K ATPase mouse mAb was purchased from Affinity Bioreagents. Anti-flotillin1 mouse mAb was purchased from BD Biosciences. Secondary antibodies conjugated to DyLight 488 or 594 and peroxidase were from Thermo Scientific and Jackson ImmunoResearch Laboratories, respectively. Secondary antibodies conjugated to IR Dye 680 or 800 were from LI-COR Biosciences. Protease inhibitors, doxycycline, and nitrocellulose membranes were obtained from Sigma-Aldrich.

Cell culture, transfection, and viruses
---------------------------------------

MDCK cells were cultured in MEM (Corning Cellgro) containing 5% fetal bovine serum (FBS) (Omega Scientific), penicillin, and streptomycin (Corning Cellgro) at 37°C and 5% CO~2~. Doxycycline-inducible stable cell lines expressing Stx3 and Stx3-5R were made as described previously ([@B68]). HEK293T cells were cultured in DMEM (Corning Cellgro) containing 10% FBS, penicillin, and streptomycin at 37°C and 5% CO~2~. Transient transfections were carried out using Lipofectamine 2000 (Life Technologies) or TurboFect (ThermoFisher) per the manufacturer's instruction.

Immortalized human foreskin fibroblast (BJ1) cells were from Clontech and human melanoma MeWo cells were a gift from Luís Montoliu (CNB, Madrid, Spain). Cells were maintained as recommended by suppliers. MeWo and BJ1 transduced cells were selected in media containing 10 and 2 µg/ml puromycin, respectively. BJ1 cells were transduced with lentiviruses expressing a c-myc-Stx3-wt or a c-myc-Stx3-5R mutant construct resistant to shRNA inhibition. BJ1 shRNA-resistant c-myc-Stx3-wt and -5R expressing cells were sorted with an ALTRA HyPerSort flow cytometer (Beckman Coulter, Palo Alto, CA).

A recombinant strain of HCMV AD169 expressing GFP under the control of the HCMV early promoter beta 2.7 gene that is expressed from 8 hpi, RecCMV ([@B50]), was propagated on BJ1 cells and titrated as previously described ([@B11]).

Lentiviral vectors for shRNA-mediated gene silencing were prepared with pMDG, p8.91, and retroviral expression plasmids encoding scrambled control (SHC002) and Stx3 shRNA TRCN0000065016 (\#304) (Mission TRC-Hs shRNA libraries, Sigma-Aldrich; [@B52]) as described ([@B55]).

Plasmids and shRNA
------------------

pcDNA4-Stx3 expression constructs were described previously ([@B68]). A QuickChange Site-directed mutagenesis kit (Agilent Technologies) was used to generate mutations in the pcDNA4-Stx3 expression construct per the manufacturer's instructions. pGFP-C2-hRab5A and pGFP-C2-hRab5A-Q79L were gifts from Dzwokai Ma (University of California, Santa Barbara). pEGFP-GPRC5B plasmid was a gift from Keith Mostov and Sang-Ho Kwon (University of California, San Francisco). mCherry-Rab5CA(Q79L) was a gift from Sergio Grinstein (Addgene plasmid \#35138) ([@B5]).

shRNA-resistant c-myc-Stx3 (GenScript, NJ) and c-myc-Stx3-5R constructs were extended with Gateway recombination sequences and transferred via pDONR201 (Invitrogen) to the lentiviral plasmid pLenti-PGK-Neo-DEST(w531-1) ([@B8]) (obtained through Addgene). Recombinant lentiviruses were prepared as described above.

Coimmunoprecipitation
---------------------

Polarized MDCK cells were lysed in a buffer containing 50 mM HEPES-KOH, pH 7.4, 50 mM potassium acetate, 1% Triton X-100, and 100 μM phenylmethane sulfonyl fluoride (PMSF) for 30 min rotating at 4°C. Samples were centrifuged at 10,000 × *g* for 10 min at 4°C. Resulting supernatant was precleared with CL2B sepharose beads for 20 min at 4°C. Precleared supernatants were incubated with protein-A beads cross-linked to anti-myc mouse immunoglobulin G (IgG) antibody (GE Healthcare Life Sciences) overnight rotating at 4°C. Beads were washed three times with lysis buffer followed by one wash with lysis buffer minus Triton X-100. Beads were resuspended in sample buffer and subjected to SDS--PAGE and Western blotting.

Immunofluorescence microscopy
-----------------------------

Cells were fixed with 4% paraformaldehyde and treated with permeabilization/blocking buffer (phosphate-buffered saline containing 5% donkey serum and 0.2% Triton X-100). Primary and secondary antibodies were diluted in permeabilization/blocking buffer. Cells were stained with 4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) and mounted with ProLong Gold mounting medium (Life Technologies).

For endocytosis assays, MDCK cells were cultured on Transwell membrane filters (Corning cellgro) with complete media in the basolateral chamber and serum-free media in the apical chamber for 4 d to ensure polarization. Anti-myc in supplemented MEM (with 20 mM HEPES, pH 7.4, and 0.6% bovine serum albumin) was added either to the basolateral or to the apical chamber for 20 min at 4°C. Cells were washed three times with ice-cold supplemented MEM before being incubated at 37°C for the indicated times and processed as above. Images were acquired using an Oympus Fluoview FV1000S Spectral Laser Scanning Confocal microscope using an Olympus UPLFLN 60× oil-immersion objective. FIJI software was used to generate plot-profile graphs for colocalization analysis and used to measure mean intensity of signal in lumens. Bar graphs and statistics were done in Prism 7 (GraphPad). Composite images were assembled in Adobe Photoshop.

Exosome purification and quantification
---------------------------------------

Human urine or media from cell cultures were subjected to three centrifugation steps; 1000 × *g* for 10 min, 10,000 × *g* for 10 min, and 100,000 × *g* for 60 min. At each step, the supernatant was transferred to a new tube. The resulting 100,000 g pellet was resuspended in Laemmli buffer and subjected to SDS--PAGE and Western blotting. Bands were quantified with Odyssey Software (LI-COR), and bar graphs and statistics were performed in Prism 7 (GraphPad).

For exosome quantification, 1 × 10^6^ MeWo cells transduced with scrambled control and Stx3 shRNAs growing in 60-mm tissue culture plates were incubated in 2 ml of tissue culture medium containing 1% fetal calf serum. After 48 h, the cells were lysed to analyze the levels of Stx3 and tubulin by immunoblot, and the supernatants were harvested to determine the number of exosomes and their size distribution by nanoparticle tracking analysis (Carr, 2007). Briefly, cell culture supernatants were centrifuged at low speed in sequential steps, and then clarified to eliminate cell debris. Clarified supernatants were diluted (1/5) in HBSS and analyzed with the use of a NanoSight LM10 instrument (NanoSight, United Kingdom) as described ([@B17]). NanoSight was calibrated with 100- and 400-nm fluorescent calibration beads (Malvern, United Kingdom).

HCMV infection in BJ1 cells
---------------------------

BJ1 parental cells and cells expressing a shRNA-resistant c-myc-Stx3-wt or -5R construct plated at 0.8 × 10^5^ cells in 16-mm wells in 24-well plates were transduced with scrambled control or Stx3 shRNAs. At 2 d posttransduction, cells were infected with RecCMV at a multiplicity of infection (MOI) of 0.3, and 4 h later puromycin was added to the culture to select transduced cells. At 4 d postinfection (dpi), a fraction of the cells were fixed, analyzed by fluorescence-activated cell sorting, and the number of infected cells was quantified by GFP expression; another fraction of the cells were lysed to quantify the expression of Stx3 by Western blot, whereas the remainder of the cells were washed and fresh medium was added to collect viruses secreted into the supernatants. At 5 dpi, supernatants were harvested and extracellular infectious particles were titrated on fresh BJ1 cells as previously described ([@B19]). Cells were fixed at 56 h postinfection, analyzed by flow cytometry, and the number of infectious cells, that is, the number of infectious virus particles, was assayed by GFP expression.
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DAPI

:   4',6-diamidino-2-phenylindole

DOX

:   doxycycline

dpi

:   days postinfection

FACS

:   fluorescence-activated cell sorting

FBS

:   fetal bovine serum

GFP

:   green fluorescent protein

HBSS

:   Hanks' balanced salt solution

HCMV

:   human cytomegalovirus

ILVs

:   intraluminal vesicles

M6PR

:   mannose 6-phosphate receptor

MDCK

:   Madin-Darby canine kidney

MOI

:   multiplicity of infection

MVBs

:   multivesicular bodies

NIH

:   National Institutes of Health

PMSF

:   phenylmethane sulfonyl fluoride

SNARE

:   soluble *N*-ethylmaleimide-sensitive factor attachment protein receptor

Stx

:   syntaxin.
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